Search - tctmd.com

Displaying 741 - 760 of 2724

Sort: Relevancy | Date

News Conference News TCT 2015

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

October 14, 2015

News Conference News TCT 2015

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Yael L. Maxwell

October 14, 2015

News Industry News

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

October 14, 2015

Presentation TCT 2015

TCT 24: Selection of Collateral Channel Guided by a Hierarchic Decision Algorithm Achieved High Technical Success Rate and Low Procedural Complication Rate in Real-world Retrograde Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO)

Presenter: Eric A. Cohen, Truls Råmunddal, Ching-Chang Huang

October 13, 2015

Presentation TCT 2015

TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics The CHAMPION PHOENIX Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Gregg W. Stone

October 13, 2015

Presentation TCT 2015

I Believe That Most PCI Procedures for Stable CAD Are NOT Worth the Time/Effort/Risk/Money!

Presenter: Eric R. Bates, Spencer B. King III, Sanjay Kaul

October 13, 2015

Presentation TCT 2015

MV Repair: At What Risk for What Benefit?

Presenter: Michael A. Borger, Marc Gillinov

October 13, 2015

Presentation TCT 2015

Advanced Patient Radiation Management (eg, Follow-up)

Presenter: Stephen Balter, Edwin M. Leidholdt, Jr.

October 13, 2015

Presentation TCT 2015

CHIP Case: Low EF, CTO, and Calcific MVD Focused Commentary

Presenter: Ajay J. Kirtane, E. Magnus Ohman, Cindy L. Grines, Holger Thiele

October 13, 2015

Presentation TCT 2015

CHIP Case: Low EF, CTO, and Calcific MVD

Presenter: Ajay J. Kirtane, E. Magnus Ohman, Cindy L. Grines, Barry D. Rutherford

October 13, 2015

Presentation TCT 2015

TAVI in Low- and Intermediate-Risk Patients

Presenter: Jose A. Condado, Celin Malkun, Ernesto M. Torresani

October 13, 2015

Presentation TCT 2015

A Low-Risk, Percutaneous Solution for Late-Stage Heart Failure (Aortix)

Presenter: Manesh R. Patel

October 13, 2015

News Conference News TCT 2015

Updates to CoreValve Extreme Risk Study Encouraging

October 13, 2015

News Industry News

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

October 13, 2015

News Daily News

High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients

Todd Neale

October 13, 2015

News Conference News TCT 2015

FDA Speaker Outlines a Novel Vision for Device Regulation

October 13, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

News Conference News TCT 2015

Darbepoetin Plus Iron Fails to Reduce Transfusion Rates After TAVR in Anemia Patients

October 13, 2015

Advertisement

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

TCT 24: Selection of Collateral Channel Guided by a Hierarchic Decision Algorithm Achieved High Technical Success Rate and Low Procedural Complication Rate in Real-world Retrograde Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO)

TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics The CHAMPION PHOENIX Trial

I Believe That Most PCI Procedures for Stable CAD Are NOT Worth the Time/Effort/Risk/Money!

MV Repair: At What Risk for What Benefit?

Advanced Patient Radiation Management (eg, Follow-up)

CHIP Case: Low EF, CTO, and Calcific MVD Focused Commentary

CHIP Case: Low EF, CTO, and Calcific MVD

TAVI in Low- and Intermediate-Risk Patients

A Low-Risk, Percutaneous Solution for Late-Stage Heart Failure (Aortix)

Updates to CoreValve Extreme Risk Study Encouraging

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients

FDA Speaker Outlines a Novel Vision for Device Regulation

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Companies With Innovative Technologies Compete in TCT Shark Tank

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

Darbepoetin Plus Iron Fails to Reduce Transfusion Rates After TAVR in Anemia Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content